Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 9/20 | 0.57 |
| ▸ | JAK1 | P23458 | 3/20 | 0.51 |
| ▸ | JAK2 | O60674 | 2/20 | 0.51 |
| ▸ | TTK | P33981 | 1/20 | 0.51 |
| ▸ | BTK | Q06187 | 2/20 | 0.51 |
| ▸ | MAP3K7 | O43318 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 6/20 | 0.47 |
| ▸ | ITK | Q08881 | 3/20 | 0.47 |
| ▸ | AXL | P30530 | 2/20 | 0.45 |
| ▸ | TYRO3 | Q06418 | 2/20 | 0.45 |
| ▸ | MERTK | Q12866 | 2/20 | 0.45 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.45 |
| ▸ | SRC | P12931 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24388354 | 1.00 | JAK3 (0.57) | JAK3JAK1JAK2TTKBTK | |
| SCHEMBL29508151 | 0.95 | JAK3 (0.54) | JAK3JAK1JAK2TTKBTK | |
| SCHEMBL29508048 | 0.95 | JAK3 (0.60) | JAK3JAK1JAK2TTKBTK | |
| SCHEMBL24388372 | 0.95 | JAK3 (0.54) | JAK3JAK1JAK2TTKBTK | |
| SCHEMBL24388371 | 0.95 | JAK3 (0.60) | JAK3JAK1JAK2TTKBTK | |
| SCHEMBL24388464 | 0.94 | JAK3 (0.54) | JAK3JAK1JAK2TTKBTK | |
| SCHEMBL29507952 | 0.94 | JAK3 (0.54) | JAK3JAK1JAK2TTKBTK | |
| SCHEMBL29508106 | 0.94 | JAK3 (0.55) | JAK3JAK1JAK2TTKBTK | |
| SCHEMBL24388549 | 0.94 | JAK3 (0.53) | JAK3JAK1JAK2TTKBTK | |
| SCHEMBL29507997 | 0.94 | JAK3 (0.53) | JAK3JAK1JAK2TTKBTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4237088-A1 | PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF | Blueprint Medicines Corporation (US) | 2023-09-06 | — | — | EP | disclosed |
| WO-2022094355-A1 | PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF | LENGO THERAPEUTICS, INC. (US) | 2022-05-05 | — | — | WO | disclosed |